You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit
The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted
AMSTERDAM — Complete revascularization improved outcomes over culprit-lesion-only stenting in older acute myocardial infarction (MI) patients, the FIRE trial affirmed. Among a population ages 75
AMSTERDAM — Ferric carboxymaltose (FCM) did not go so far as to improve hard outcomes in people with heart failure with reduced ejection fraction (HFrEF)
TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange,
Nair is a cardiologist. From oncology to rheumatology, therapy with monoclonal antibodies have rapidly changed the face of modern medicine. Frankly, I am dead scared